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The valid assessment of the impact of transplantation on psychological well-being
is highly relevant to optimize treatment. However, to date there is no standardized
instrument available in Spain. The Transplant Effects Questionnaire (TxEQ) evaluates the
specific problems associated with organ transplantation, such as worry about transplant,
guilt regarding the donor, disclosure of having undergone transplantation, adherence
to medical treatment and responsibility toward the donor, family, friends, or medical
staff. Against this backdrop the English original version of the TxEQ was translated
into Spanish and validated in a sample of 240 liver transplant recipients. Participants
also filled in the Posttraumatic Growth Inventory (PTGI), and the 12-Item Short Form
Health Survey (SF-12v.2). Confirmatory factor analysis of the TxEQ-Spanish revealed a
five-factor structure equivalent to the English original version, and satisfactory internal
consistency (Cronbach’s alpha: worry α = 0.82, guilt α = 0.77, disclosure α = 0.91,
adherence α = 0.82, responsibility α = 0.83). Results showed that better mental quality
of life was associated with higher adherence and disclosure, as well as less worry and
guilt. Higher posttraumatic growth was significantly associated with worry, guilt, and
responsibility. Interestingly, the most powerful predictor of posttraumatic growth was
worry. Analysis of variance showed an interaction effect of PTG and mental quality
of life on adherence, with medium PTG being associated with significantly stronger
adherence in participants with better mental quality of life. In conclusion our study could
successfully adapt and validate the Spanish version of the TxEQ in a large sample of
Pérez-San-Gregorio et al. Transplant Effects Questionnaire (TxEQ-Spanish)
liver transplant recipients. Our findings show a complex relationship between emotional
reactions to transplantation, mental quality of life, and posttraumatic growth, which give
further insight into inner processes supporting psychological well-being and adherence
after liver transplantation.
Keywords: transplant effects questionnaire, TxEQ-Spanish, posttraumatic growth, quality of life, liver
transplantation
INTRODUCTION
Transplantation has a great impact on the patients’ physical
and psychological well-being. Standardized psychometric
instruments such as the Transplant Effects Questionnaire
(TxEQ) are important to be able to assess and compare these
effects and may help to optimize treatment. The English original
version of this questionnaire was developed and tested with
kidney transplant recipients [1]. Later, it was translated to other
languages. The German version (TxEQ-D) was validated in a
group of heart, lung, liver, and kidney transplant recipients [2],
the Dutch version (TxEQ-NL) in a group of liver transplant
recipients [3], and the Polish version in a group of heart
transplant recipients [4]. The factor structure of the above
mentioned versions is similar to the original version consisting
of the five subscales worry, guilt, disclosure, adherence, and
responsibility. In the German version the five-factor structure
was confirmed in Confirmatory Factor Analysis (CFA) by a
scree plot [2] and in the Dutch version the Root Means Square
Error of Approximation (RMSEA = 0.063) as well as the Akaike
Information Criterion (AIC = 19578) confirmed good model fit
[3]. For the Polish version no indices of model fit were presented
[4]. Regarding reliability Cronbach’s alpha varied between
0.71–0.79 in the German version [2], 0.66–0.79 in the Dutch
version [3], and 0.61–0.72 in the Polish version [4] compared to
0.72–0.86 in the English original version [1].
Despite the growing importance of transplantation medicine
in Spain [5] there is no Spanish translation of the TxEQ. The
TxEQ has successfully been used to assess the impact of different
forms of transplantation (living vs. deceased donor) [6, 7] and
different organ types (heart, lung, liver, kidney) on quality of
life. Thus, in a sample of 370 solid organ transplant recipients,
18.2% of liver recipients worried about the transplant compared
to 14.4% of kidney recipients, 3.9% in lung recipients, and 2.4% of
heart recipients [8]. Another study revealed that recipients after
living donation tend to experience more guilt toward the donor
compared to transplant recipients of deceased donors [7].
There is growing evidence that recipients’ quality of life
is closely connected to their ability to adapt to the new
situation after a traumatic experience [9]. This ability has been
described by Tedeschi and Calhoun [10, 11] as posttraumatic
growth and several studies showed its relevance as a protective
factor for psychological well-being after transplantation [12–
15]. According to Tedeschi and Calhoun the experience of
growth is often motivated by the experience of personal distress
and worries and the inner need to find a new intra-psychic
balance. The importance of worry as predictor of posttraumatic
growth has been confirmed in cancer patients [16, 17]. A
successful adaptation of the transplant recipient may result in a
modification of coping strategies [18], a shift in priorities, and
a change in family ties [19]. However, the complex relationship
between specific emotional reactions to transplantation as
measured by the TxEQ, posttraumatic growth and quality of life
is not fully understood.
Against this backdrop our study aimed at an adaptation of the
English TxEQ to Spanish and a validation of the Spanish version
(TxEQ-Spanish) in a sample of liver transplant recipients. We
had the following hypotheses. First, the TxEQ-Spanish has a five-
factor structure similar to the original version with the subscales
worry, guilt, disclosure, adherence, and responsibility. Second,
posttraumatic growth is related to higher scores on worry, guilt,
disclosure, adherence, and responsibility. Third, mental quality
of life is related to lower scores on worry and guilt and higher
scores on disclosure, adherence, and responsibility. Finally, in
accordance with the theory of Tedeschi and Calhoun [10, 11]
and previous studies in cancer patients [16, 17] we assumed
worry to be the most powerful predictor among TxEQ scales of
posttraumatic growth after transplantation.
MATERIALS AND METHODS
Participants and Procedure
This research was approved by the Ethics Committee of the
Virgen del Rocío University Hospital of Seville. All patients gave
their informed consent for participation. A group of 240 liver
transplant recipients was selected (185 men and 55 women),
with a mean age of 60.21 ± 9.30 years. 79.2% had a stable
partnership and 61.7, 22.5, and 15.8% had a low, medium, and
high education, respectively. The average time that had elapsed
since the transplant was 87.77 ± 66.19 months. The etiology
of the liver disease was as follows: alcoholic cirrhosis (32.1%),
hepatocellular carcinoma (27.9%), hepatitis C-related cirrhosis
(17.1%), hepatitis B-related cirrhosis (5%), and others (17.9%).
The liver received by all patients was from a donor who had died
from the following causes: cerebrovascular accidents (59.9%),
cranioencephalic traumas (27%), and others (13.1%). For the
specific patient selection procedure and inclusion criteria see
Pérez-San-Gregorio et al. [9].
Instruments
Transplant Effects Questionnaire (TxEQ; [1])
The English original version consists of 23 items scored on a
5-point Likert scale ranging from “strongly agree” to “strongly
disagree.” It contains five subscales that assess worry about the
transplant (six items, e.g., “I am worried about damaging my
transplant”), guilt regarding the donor (five items, e.g., “I feel
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guilty about having taken advantage of the donor”), disclosure
(three items; e.g., “I avoid telling other people that I have a
transplant”), adherence (five items, e.g., “Sometimes I do not take
my anti-rejection medicines”), and responsibility (four items,
e.g., “I think that I have responsibility to the transplant team to
do well”). The score of each subscale is calculated by dividing the
sum score by the number of items. Higher scores show a higher
degree of the dimension concerned.
The factor structure was similar in all versions derived
from this questionnaire, Table 1 presents subscales’ internal
consistency as measured by Cronbach’s alpha.
Posttraumatic Growth Inventory (PTGI; [10])
This questionnaire consists of 21 items scored on a 6-point
Likert scale (0 to 5) ranging from “no change” to “a very great
degree of change,” thereby evaluating the perception of personal
benefits in survivors of traumatic events. Test interpretation
provides a total score of posttraumatic growth and the following
five subdimensions: relating to others, new possibilities, personal
strength, spiritual change, and appreciation of life. We used
the Spanish version by Weiss and Berger [20]. Three equal-
sized groups with different levels of posttraumatic growth (low,
medium, high) were formed. A higher score showed more
posttraumatic growth. Cronbach’s alpha was 0.94 for the sum
scale and 0.74 to 0.88 for the subscales.
12-Item Short Form Health Survey (SF-12v.2; [21, 22])
This instrument is made up of 12 items scored on either 3 or 5-
point Likert-scales. It evaluates the following eight dimensions
of health-related quality of life covering the previous 4 weeks:
physical functioning, role-physical, bodily pain, general health,
vitality, social functioning, role-emotional, and mental health.
The sum score of the two components Physical Component
Summary (PCS) and Mental Component Summary (MCS) was
calculated by the Quality Metric Health OutcomesTM Scoring
Software 5.0. The sum score can range from 0 (worst state of
health) to 100 (best state of health). Based on the liver transplant
recipients’ scores on the MCS, two groups of the same size with
better or worse mental quality of life were formed. Cronbach’s
alpha was 0.92 for the PCS and 0.88 for the MCS [21].
Translation and Statistical Analysis
Data were analyzed and graphics were produced using the
software programs, Mplus v.7 [23] and SPSS 22 (IBM
Corporation, Armonk, NY, United States) for Windows PC.
TABLE 1 | Cronbach’s alpha for the TxEQ-Spanish and the English, German,
Dutch, and Polish versions.
[1]
(English)
[2]
(German)
[3]
(Dutch)
[4]
(Polish)
TxEQ-
Spanish
Worry 0.81 0.73 0.68 0.61 0.82
Guilt 0.76 0.74 0.66 0.63 0.77
Disclosure 0.86 0.71 0.79 0.72 0.91
Adherence 0.79 0.79 0.78 0.61 0.82
Responsibility 0.72 0.73 0.66 0.63 0.83
Translation of the Transplant Effects Questionnaire
(TxEQ) Into Spanish
The translation of the English original version of the TxEQ
into Spanish strictly followed the guidelines for the process of
cross-cultural adaptation of self-report measures by Beaton et al.
[24] as well as the guidelines to quality control by Hambleton
and Zenisky [25]. After requesting permission of the original
authors the questionnaire was translated into Spanish by two
psychology professors with advanced levels of English (stage
I). After completion of both translations, translated items were
compared and checked. Non-conformities were discussed until a
consensus was reached and a final version was drafted (stage II).
This version was translated back into English by two professional
translators (stage III). On the basis of these translations and all
previous reports a final version was produced by translators as
well as other research team members (stage IV). This Spanish
version was pilot tested for comprehensibility in a small group
of transplant recipients (n = 10) (stage V). All participants
confirmed the comprehensibility of the TxEQ-Spanish.
Statistical Analysis
To validate the Spanish version of the TxEQ and to analyse
the relationship between the TxEQ and quality of life as well
as posttraumatic growth the following statistical analyses were
applied.
A Confirmatory Factor Analysis (CFA) was performed to
replicate the five-factor structure of the English original version
of the TxEQ. In the first place, it was confirmed that the data
matrix was adequate for factor analysis by measuring sample
adequacy with the Kaiser-Meyer-Olkin Test (≥0.08) and the
Bartlett test of sphericity (p ≤ 0.0001). To determine the best
estimation method, the assumption of multivariate normality of
the data was tested, checking to see whether the Mardia test
[26] showed a standardized value over 5 [27]. For the fit indexes
and model evaluation, the adequacy of the factorial solution was
analyzed in several different ways: (a) indications of model fit:
we took into account whether the Comparative Fit Index (CFI)
and Non-Normed Fit Index (NNFI) or the equivalent Tucker
and Lewis Index (TLI) values were near to or over 0.90, whether
the Root Mean Square Error of Approximation (RMSEA) was
less than 0.08 and whether the Test of Approximate Fit of
RMSEA was non-significant [28, 29], and (b) significance of the
parameters.
To analyze the internal consistency of the questionnaire,
Cronbach’s alpha coefficients were calculated for all dimensions,
considering an internal consistency of at least 0.70 as adequate
[30].
Pearson’s chi-squared test was used to compare socio-
demographic and clinical variables (gender, marital status,
education, and etiology of the disease) in the patient subgroups.
For the quantitative variables (age and time elapsed since
transplantation), a one-way ANOVA was calculated. Before
analysis of the relationship between TxEQ subscales, quality
of life (SF12) and posttraumatic growth (PTGI) we checked
data of the different scales for normality distribution by the
Kolmogorov-Smirnov test, however scales were not normally
distributed. The Levene-test for the equality of variances was not
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significant so that data showed homoscedasticity. According to
statistical literature [31–33] ANOVA and Pearson’s correlation
produce reliable results under these circumstances given a
large sample size of n = 240. A 3x2 factorial ANOVA
was performed to evaluate the influence of posttraumatic
growth level (low, medium, high) and MCS (worse, better)
on transplantation effects. Pearson’s correlation was used
to analyze associations between TxEQ-Spanish dimensions,
posttraumatic growth, and mental quality of life. Cohen’s d (for
quantitative variables) and Cohen’s w (for qualitative variables)
were computed as a measure of effect size. Effect sizes were
interpreted as follows: for Cohen’s d < 0.20=null effect size;
≥0.20<0.50=small; ≥0.50<0.80=moderate; ≥0.80=large. And
for Cohen’s w < 0.10=null effect size; ≥0.10<0.30=small;
≥0.30<0.50=moderate; ≥0.50=large [34].
Finally, we performed a stepwise multiple linear regression
analysis to predict posttraumatic growth of liver transplant
recipients (criterion or dependent variable) by means of
seven predictor variables (worry, guilt, disclosure, adherence,
responsibility, MCS, and PCS). Statistical requirements
for the implementation of linear regression analysis
(linearity, independence of residuals, homoscedasticity,
no-multicollinearity) were fulfilled.
RESULTS
Spanish Adaptation and Validation of the
Transplant Effects Questionnaire (TxEQ)
On an exploratory level, we confirmed that the matrix was
suitable for factoring. Kaiser-Meyer-Olkin’s measurement of
sample adequacy was 0.80, which is considered satisfactory [35]
and the Bartlett’s sphericity test was not significant (p ≤ 0.0001).
On a descriptive level, participant responses did not show
any missing values or outliers. The mean scores for all 23 items
varied from 1.63 ± 0.93 to 4.66 ± 0.90, with skewness (−3.11,
1.78) and kurtosis (−1.48, 9.19) which deviated from the range
of −1 and 1 required to consider distribution of the items
normal [36]. There was no normal distribution of data (Mardia’s
coefficient = 36.68; value higher than 5.00; [27]). Consequently,
Robust Maximum Likelihood was employed for CFA calculation.
Correlations between the TxEQ-Spanish subscales, posttraumatic
growth and mental quality of life are presented in Table 2.
In the next step of analysis the original five-factor structure
was tested. Certain adjustments had to be made for satisfactory
fit and significance of all the model parameters. Specifically,
three adjustments were made to the original structure: First, a
new parameter was added to the model, the residual covariance
of items 6 and 9, both indicators of the same responsibility
dimension (Figure 1). Second, significant correlations were
allowed between the following dimensions: worry and guilt,
worry and disclosure, worry and responsibility, and guilt and
disclosure. There were no other significant inter-correlations.
Third, item 8 (“I do not have any feeling of guilt toward
the donor”) was eliminated, because it showed a saturation
of < 0.2 and was negatively correlated to the corresponding
dimension (guilt). The final version of the scale is shown in
Appendix 1 in Supplementary Material. Moreover, in Appendix
2 in Supplementary Material we present a table comparing the
TxEQ-Spanish and the English original version on an item to
item basis.
After having made these adjustments, the fit indices were
satisfactory: CFI = 0.90 and TLI = 0.89; RMSEA = 0.063 (H0:
RMSEA < 0.05; p = 0.013; 90% confidence interval = 0.053–
0.072). Figure 1 shows the diagram of the resulting model in
which the standardized factor weights are given together with
standard error and residuals for each item, as well as the
covariance between dimensions and errors in items 6 and 9. All
the estimated parameters were statistically significant (p < 0.01),
the values were as follows: worry 0.58 to 0.75 (M = 0.65,
SD = 0.05), guilt 0.42 to 0.89 (M = 0.70, SD = 0.05), disclosure
0.84 to 0.95 (M = 0.88, SD = 0.04), adherence 0.43 to 0.91
(M = 0.68, SD= 0.07), and responsibility 0.48 to 0.92 (M = 0.70,
SD = 0.06). The proportion of variance explained by the
predictor variables varied from 0.17 to 0.85. In the final model
a correlation of r = 0.42 (p < 0.001) was observed between
the factors worry and guilt, r = −0.22 (p = 0.001) between
worry and disclosure, r = 0.32 (p = 0.001) between worry and
responsibility, and r = −0.43 (p < 0.001) between guilt and
TABLE 2 | Correlations between the TxEQ-Spanish subscales, posttraumatic growth, and mental quality of life.
Posttraumatic growth
r
(p)
Mental quality of life
r
(p)
Worry
r
(p)
Guilta
r
(p)
Disclosure
r
(p)
Adherence
r
(p)
Worry 0.37
(<0.001)
−0.22
(0.001)
Guilta 0.13
(0.046)
−0.13
(0.036)
0.37
(<0.001)
Disclosure 0.02
(0.741)
0.19
(0.002)
−0.21
(0.001)
−0.43
(<0.001)
Adherence 0.08
(0.238)
0.16
(0.014)
−0.09
(0.164)
−0.28
(<0.001)
0.44
(<0.001)
Responsibility 0.25
(<0.001)
0.01
(0.876)
0.33
(<0.001)
0.14
(0.030)
−0.06
(0.319)
0.10
(0.120)
aTxEQ [1] item 8 (“I do not have any feeling of guilt toward the donor”) was not included in the factor computation.
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disclosure. The correlation between errors on items 6 and 9 was
r = 0.64 (p < 0.001).
Cronbach’s alpha for internal consistency as a measure of
reliability was satisfactory for all five subscales: worry 0.82, guilt
0.77, disclosure 0.91, adherence 0.82, and responsibility 0.83
(Table 1).
Posttraumatic Growth and Mental Quality
of Life: Influence on the Effects of the
Transplant
Based on patients’ total score on the PTGI, three equal-sized
subgroups were created: low score (n = 80 patients, 33.3% of
the sample, 0 to 59 points), medium score (n = 80 patients,
33.3% of the sample, 60 to 77 points), and high score (n = 80
patients, 33.3% of the sample, 78 to 105 points). There were no
significant differences between subgroups in age (p = 0.506),
gender (p = 0.639, w = 0.06, null effect size), marital status
(p = 0.720, w = 0.05, null effect size), education (p = 0.187,
w = 0.16, small effect size), time elapsed since transplantation
FIGURE 1 | CFA diagram. Standardized factor loadings with standard error of
the items and residuals and co-variance between dimensions.
(p = 0.227), or etiology of the liver disease (p = 0.082,
w = 0.24, small effect size). In a further step of analysis,
another two subgroups of equal size were formed based on
the SF-12 MCS: lower score or worse mental health (n = 120,
50% of the sample, ≤52.87 points) and higher score or better
mental health (n = 120, 50% of the sample, >52.87 points).
There were no significant differences between both subgroups
regarding age (p = 0.105), gender (p = 0.091, w = −0.11,
small effect size), marital status (p = 0.026, w = −0.14,
small effect size), education (p = 0.075, w = 0.15, small
effect size), time elapsed since transplantation (p = 0.926), or
etiology of the liver disease (p = 0.442, w = 0.12, small effect
size).
In the analysis of variance only the dimension adherence
showed an interaction effect between the two factors
posttraumatic growth and mental quality of life (p = 0.032)
(Table 3). Figure 2 demonstrates this relationship. There
was only a significant difference in adherence (p = 0.001,
d = −0.76) between patients with worse and better mental
quality of life if they showed medium posttraumatic growth;
better quality of life was associated with stronger adherence
of medium effect size. This difference disappeared when
posttraumatic growth was low (p = 0.411, d = −0.18,
null effect size) or high (p = 0.781, d = 0.06, null effect
size). Moreover, as shown in Table 2, adherence showed
a significantly positive correlation with mental quality
of life (r = 0.16, p = 0.014) and disclosure (r = 0.44,
p < 0.001), and a negative correlation with guilt (r = −0.28,
p < 0.001).
As shown in Table 3, Figure 3, the posttraumatic
growth main effect was significant for the dimensions
worry (p < 0.001) and responsibility (p = 0.002).
Scores on both dimensions were significantly higher
in patients with high compared to low posttraumatic
growth (worry, p < 0.001, d = −0.91, large effect size;
TABLE 3 | Influence of posttraumatic growth and mental quality of life on the
TxEQ-Spanish subscales (3x2 factorial ANOVA).
Main effects Interaction
effects
Posttraumatic
growth
F(2,234) (p)
Mental
quality of life
F(1,234) (p)
F(2,234) (p)
Worry 16.68
(<0.001)
14.45
(<0.001)
1.23
(0.295)
Guilta 1.64
(0.195)
5.99
(0.015)
0.30
(0.739)
Disclosure 0.17
(0.845)
4.38
(0.037)
0.71
(0.493)
Adherence 0.76
(0.468)
5.11
(0.025)
3.49
(0.032)
Responsibility 6.41
(0.002)
0.00
(0.946)
0.55
(0.576)
aTxEQ [1] item 8 (“I do not have any feeling of guilt toward the donor”) was not included
in the factor computation.
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FIGURE 2 | Simple effects on adherence. N, Null effect size; S, Small effect size; M, Medium effect size.
responsibility, p = 0.002, d = −0.54, medium effect
size). Posttraumatic growth was also positively correlated
with worry (r = 0.37, p < 0.001), guilt (r = 0.13,
p = 0.046), and responsibility (r = 0.25, p < 0.001)
(Table 2).
The main effect of mental quality of life was significant
regarding the dimensions worry (p < 0.001, d = 0.49,
small effect size), guilt (p = 0.015, d = 0.32, small
effect size), disclosure (p = 0.037, d = −0.27, small
effect size), and adherence (p = 0.025, d = −0.29, small
effect size) (Table 3, Figure 3). Patients with better mental
quality of life scored higher on disclosure and adherence,
and lower on worry and guilt, which corresponded to
significantly positive or negative correlations between
mental quality of life and above mentioned dimensions
(Table 2).
Predictors of Posttraumatic Growth
The results of the multiple linear regression analysis with
posttraumatic growth as dependent variable and mental and
physical quality of life, worry, guilt, disclosure, adherence, and
responsibility as predictors are presented in Table 4. The final
model [F(3, 236) = 16.74, p < 0.001] consisted of the three
significant predictors worry (p < 0.001), PCS (p = 0.017)
and responsibility (p = 0.034). This model explained 17.5%
(R2 = 0.175) of the variance observed in posttraumatic
growth.
DISCUSSION
Spanish Adaptation and Validation of the
Transplant Effects Questionnaire
(TxEQ-Spanish)
To date there is no standardized instrument available in Spain to
assess the impact of transplantation on psychological well-being.
Against this backdrop the current study aimed at translating
the English original version of the TxEQ into Spanish and
validate the Spanish version in a large sample of liver transplant
recipients. In our methodological approach we followed the
guidelines for the process of cross-cultural adaptation of self-
report measures by Beaton et al. [24]. Thus, the adaptation
procedure embraced five carefully designed steps, to ensure
soundness of the final version. By means of this approach
we ensured semantic, idiomatic experiential, and conceptual
equivalence of both questionnaires and the comparability of
responses in English and Spanish speaking populations. The
verification of scaling requirements by analyzing the factor
structure and reliablity of the TxEQ was implemented in the
next step [24] to ensure psychometric quality of the Spanish
version. CFA of the TxEQ-Spanish revealed adequate fit with
the original English version of the TxEQ [1] and confirmed a
robust five-factor structure. After careful analysis of the internal
consistency of all subscales one item (item 8: “I do not have
any feelings of guilt toward the donor”) showed a particularly
low loading on the factor guilt and had to be excluded from
the questionnaire. One possible reason for the low association of
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FIGURE 3 | Influence of posttraumatic growth and mental quality of life on the TxEQ-Spanish subscales. N, Null effect size; S, Small effect size; M, Medium effect
size; L, Large effect size.
this item with the factor guilt might be that the translation into
Spanish led to a double negative. This grammatical construction
may have led to difficulties in comprehensibility, particularly in
recipients with a low level of formal education, which made
up 61.7% of patients in our sample. This modification of the
Spanish version does not necessarily result in a relevant reduction
in information provided by the subscale “guilt regarding the
donor,” since it contains another item (item 13: “I feel guilty about
having taken advantage of the donor”) with similar content. In
the final version of the TxEQ-Spanish the internal consistency
scores were satisfactory ranging from 0.77 to 0.91. Consistency
scores were even higher than in the English original version [1]
and the translated versions in German [2], Dutch [3], or Polish
[4]. Therefore, our hypothesis that the TxEQ-Spanish has a factor
structure (worry, guilt, disclosure, adherence, and responsibility)
similar to the original version and shows satisfactory reliability
has been confirmed.
Mental Quality of Life, Posttraumatic
Growth, and TxEQ-Spanish
Moreover, we analyzed the relationship between recipients’
emotional reactions to transplantation, their mental quality of
life and posttraumatic growth. In this context adherence to
treatment and medication is of specific interest to optimize long-
term outcome of transplantation. Analysis of variance showed
an interaction effect between posttraumatic growth and mental
quality of life on therapeutic adherence. Better mental quality of
life was associated with more adherence merely in patients with
TABLE 4 | Repercussions of liver transplantation (worry, guilt, disclosure,
adherence, responsibility, MCS, and PCS) as predictors of posttraumatic growth.
Predictor variables B SE β t
(p)
R2 1R2
Step 1 0.137 0.137
Worry 8.54 1.39 0.37 6.14
(<0.001)
Step 2 0.160 0.023
Worry 9.24 1.40 0.40 6.58
(<0.001)
PCS 0.32 0.13 0.15 2.54
(0.012)
Step 3 0.175 0.016
Worry 8.17 1.48 0.35 5.51
(<0.001)
PCSa 0.30 0.13 0.14 2.40
(0.017)
Responsibility 2.92 1.36 0.13 2.14
(0.034)
aPCS, physical component summary.
medium posttraumatic growth. A positive association between
mental health and adherence is in line with other studies [2,
6, 37–39] and confirms our hypothesis. However, it is not easy
to explain, why this difference can only be seen in recipients
with medium posttraumatic growth. One might argue that—
taking mental health into account—there is no linear association
between adherence and posttraumatic growth as Figure 3 might
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suggest, but rather a u-shaped or reverse u-shaped connection
as shown in Figure 2. This relationship could be explained by
the fact that adherence to medication worsens if the patient
feels cognitively overloaded [40] and improves if simplification of
medication regimen lowers the cognitive load [41]. Posttraumatic
growth is defined by Tedeschi and Calhoun [10, 11] as a
process, which takes time and absorbs a lot of cognitive resources
to be able to form cognitive schemata reconciling existential
opposites. If recipients are involved in posttraumatic growth,
effects may largely depend on the extent of involvement. A
moderate involvement in the process of posttraumatic growth
(medium PTG)may be associated with disadvantages concerning
treatment in recipients with worse mental health compared
to those with better mental health, as worse mental health is
associated with fewer mental resources and recipients may be
overwhelmed by inner conflicts (“tunnel vision”). The mental
overload could be mirrored in a positive response to items
from the adherence scale such as “Sometimes I forget to take
my anti-rejection medicines” and “When I am too busy I may
forget my anti-rejection medicines.” Obviously, this explanation
is highly speculative, and does not explain convincingly the
lack of differences in the group with high PTG. Nevertheless,
the aspect that posttraumatic growth is a resource consuming
cognitive process needs to be taken into account to be able to
understand the complexity of its effects. Significant predictors of
PTG were the degree of physical complaints (PCS), worry, and
responsibility with worry being the most important predictor.
Posttraumatic growth implies a gain in self-awareness and
spirituality, a re-definition of personal relationships and a greater
appreciation of life with all its possibilities [10, 11]. At first
sight it may be difficult to understand the relationship between
worry and PTG. However, worries about the transplantation
and all its implications, which are closely connected to the
subjective experience of physical health (PCS), are the necessary
predisposition for posttraumatic growth. The items “I am
worried about damaging my transplant” or “I am hesitant to
engage in certain activities because I am afraid of doing harm
to my transplant” belonging to the worry-subscale demonstrate
that worries affect all aspects of recipients’ life. The process
of posttraumatic growth is fueled by these repeated worries
on the one hand and a sense of responsibility on the other,
which enables the recipient to accept inner development as a
personal task and not simply rely on fate. This responsibility
also embraces a responsibility toward his own health and
significant others. A sense of personal responsibility is closely
connected to personality traits such as self-directedness and the
psychological construct of self-efficacy, which both are strong
predictors of psychological well-being and positive outcome after
psychotherapy [42]. In summary, the prediction of posttraumatic
growth by worry, physical health and responsibility gives further
insight into those factors advancing positive change after liver
transplantation [12, 14, 15, 19].
Regarding adherence our study confirmed a significant
positive association with disclosure and a negative association
with guilt [7, 43]. The difficulty of recipients to disclose their
transplantation to others and a feeling of guilt toward the donor
makes it difficult for recipients to exercise the adequate self-
care. Thus, they may avoid taking their immunosuppressants in
circumstances, where others may realize it or they may even ask
themselves, whether they deserve to survive. Early identification
of these problems and adequate treatment are crucial to avoid
non-adherence resulting in rejection episodes and graft losses
[44]. The importance of early psychological intervention can also
be derived from the fact that a better mental quality of life is
associated with more disclosure and less worry and guilt, which
is in line with a previous study [2].
Our study shows several limitations. First, our sample
consisted of liver transplant recipients, therefore our findings
cannot be transferred to recipients of other organs. Second, all
liver transplants were from deceased donors. Findings could
be different in living donor liver transplantation [6, 7]. Third,
recruitment of patients took place at a single site which
may limit external validity of findings. Fourth, our cross-
sectional study design does not allow for the investigation of
longitudinal changes in respective questionnaires. Fifth, in our
statistical analysis subgroups were created on the basis of sample
distribution and not on the basis of validated cut-off values,
which may restrict generalizability of study results.
Nevertheless our study successfully adapted and validated the
TxEQ-Spanish in a large sample of liver transplant recipients,
which allows for the future investigation of the psychological
effects of transplantation by a psychometrically sound instrument
in Spain.
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